Adaptive Biotechnologies's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Adaptive Biotechnologies is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 45.78M	$ 37.92M	$ 48.93M	$ 37.65M	$ 55.20M
Gross Profit	$ 26.17M	$ 18.57M	$ 31.02M	$ 18.97M	$ 38.61M
EBIT	$ -15.60M	$ -46.67M	$ -44.21M	$ -54.17M	$ -39.19M
EBITDA	$ -13.20M	$ -43.61M	$ -40.47M	$ -50.35M	-
Net Income Common Stockholders	$ -69.44M	$ -50.30M	$ -47.81M	$ -57.70M	$ -40.13M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 346.40M	$ 371.13M	$ 417.23M	$ 440.69M	$ 498.20M
Total Assets	$ 661.13M	$ 717.68M	$ 764.52M	$ 791.46M	$ 773.17M
Total Debt	$ 229.43M	$ 231.23M	$ 103.52M	$ 105.78M	$ 108.00M
Net Debt	$ -116.97M	$ -139.90M	$ -313.71M	$ -334.91M	$ -390.19M
Total Liabilities	$ 352.86M	$ 356.05M	$ 368.57M	$ 367.51M	$ 856.62M
Stockholders Equity	$ 308.40M	$ 361.73M	$ 396.04M	$ 424.02M	$ 464.17M
Cash Flow	-
Free Cash Flow	$ -28.23M	$ -49.46M	$ -27.25M	$ -62.08M	$ -32.58M
Operating Cash Flow	$ -26.93M	$ -46.68M	$ -23.56M	$ -59.15M	$ -30.04M
Investing Cash Flow	$ 3.21M	$ 26.14M	$ 37.32M	$ 62.98M	$ -97.54M
Financing Cash Flow	$ 87.00K	$ 17.00K	$ 1.47M	$ 672.00K	$ 6.00K

Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

Income Statement >

Adaptive Biotechnologies Debt to Assets

Balance Sheet >

Adaptive Biotechnologies Cash Flow

Cash Flow >

Adaptive Biotechnologies Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing